bso cancer treatment glutathione Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Inhibiting glutathione synthesis sensitizes breast
Inhibiting glutathione synthesis sensitizes breast cancer cells to Download Scientific Diagram Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal
Pay in 4 interest-free payments of $5.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



